Published in J Lipid Res on February 16, 2005
Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J Lipid Res (2009) 1.11
The neuropathology of obesity: insights from human disease. Acta Neuropathol (2013) 0.91
Immune response to lipoproteins in atherosclerosis. Cholesterol (2012) 0.90
Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant. J Immunol (2014) 0.86
Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells. Sci Rep (2016) 0.80
Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio. J Blood Med (2016) 0.75
Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling. PLoS Negl Trop Dis (2017) 0.75
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol (2003) 3.35
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med (2009) 2.12
Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science (2007) 2.06
Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler Thromb Vasc Biol (2003) 1.50
Dexamethasone promotes tolerance in vivo by enriching CD11clo CD40lo tolerogenic macrophages. Eur J Immunol (2012) 1.45
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res (2008) 1.39
Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol (2011) 1.16
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. J Lipid Res (2009) 1.16
Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). J Biol Chem (2003) 1.13
Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am J Pathol (2007) 1.09
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res (2003) 1.09
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J (2010) 0.99
Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther (2008) 0.99
Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J Lipid Res (2003) 0.99
Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry (2006) 0.99
Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol (2002) 0.98
Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry (2005) 0.97
VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res (2008) 0.97
Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol (2012) 0.97
Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis (2008) 0.95
Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure. Biochemistry (2005) 0.93
Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges. Biochem J (2002) 0.89
The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J Biol Chem (2008) 0.88
Arginine/arginase NO NO NO. Arterioscler Thromb Vasc Biol (2006) 0.85
Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochim Biophys Acta (2011) 0.84
Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. J Biol Chem (2001) 0.84
Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis (2009) 0.84
Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis (2005) 0.84
Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res (2013) 0.83
Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res (2004) 0.83
Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arterioscler Thromb Vasc Biol (2013) 0.83
Import of yeast mitochondrial transcription factor (Mtf1p) via a nonconventional pathway. J Biol Chem (2002) 0.83
ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res (2012) 0.82
Requirement of different mitochondrial targeting sequences of the yeast mitochondrial transcription factor Mtf1p when synthesized in alternative translation systems. Biochem J (2004) 0.82
A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol (2011) 0.80
Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE. J Neurochem (2003) 0.80
Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. J Lipid Res (2012) 0.80
LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells. PLoS One (2013) 0.79
High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. Arterioscler Thromb Vasc Biol (2010) 0.78
Chemical colloids versus biological colloids: a comparative study for the elucidation of the mechanism of protein fiber formation. Biochemistry (2005) 0.77
Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. J Lipid Res (2013) 0.76
Do natural killer cells participate in a killer vascular disease? Arterioscler Thromb Vasc Biol (2002) 0.76
The ABC transporters and the thickening cholesterol plot. Curr Opin Lipidol (2011) 0.75
Murine atherosclerosis. Part III. Curr Drug Targets (2008) 0.75
ABC transporters: lipid transport and inflammation. Curr Opin Lipidol (2010) 0.75
Atherosclerosis: beyond cholesterol. Curr Opin Lipidol (2011) 0.75